Cellier-Goetghebeur, S.; Lafontaine, K.; Lemay-St-Denis, C.; Tsamo, P.; Bonneau-Burke, A.; Copp, J.N.; Pelletier, J.N.
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance. Antibiotics 2022, 11, 1768.
https://doi.org/10.3390/antibiotics11121768
AMA Style
Cellier-Goetghebeur S, Lafontaine K, Lemay-St-Denis C, Tsamo P, Bonneau-Burke A, Copp JN, Pelletier JN.
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance. Antibiotics. 2022; 11(12):1768.
https://doi.org/10.3390/antibiotics11121768
Chicago/Turabian Style
Cellier-Goetghebeur, Stella, Kiana Lafontaine, Claudèle Lemay-St-Denis, Princesse Tsamo, Alexis Bonneau-Burke, Janine N. Copp, and Joelle N. Pelletier.
2022. "Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance" Antibiotics 11, no. 12: 1768.
https://doi.org/10.3390/antibiotics11121768
APA Style
Cellier-Goetghebeur, S., Lafontaine, K., Lemay-St-Denis, C., Tsamo, P., Bonneau-Burke, A., Copp, J. N., & Pelletier, J. N.
(2022). Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance. Antibiotics, 11(12), 1768.
https://doi.org/10.3390/antibiotics11121768
